Adjuvant Capital leads Series A round for 54gene

54gene, an African genomics research, services and development company, has raised $15 million in Series A funding.

54gene, an African genomics research, services and development company, has raised $15 million in Series A funding. Adjuvant Capital led the round.

Source: Press Release